Preclinical Development of Monoclonal Antibodies and Related Biologicals

Preclinical Development of Monoclonal Antibodies and Related Biologicals
Article by ReportsandReports
Monoclonal antibodies form the fastest growing segment of the pharmaceutical industry, with total annual sales expected to top billion in the next four years. 23 full-size monoclonal antibodies and three monoclonal antibody fragments have been launched so far, several having quickly reached ‘blockbuster status’ (annual sales of over billion). Between 1995 and 2007, the number of

Read more about allergy and ...